{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:29:03Z","timestamp":1785414543067,"version":"3.56.0"},"reference-count":31,"publisher":"AOSIS","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Background:\u00a0Surveillance of drug-resistant infections is crucial for antimicrobial resistance (AMR) control. Implementing surveillance in low- and middle-income countries (LMICs) is challenging.\n\nAim:\u00a0To investigate bacteraemia and describe AMR surveillance.\n\nSetting:\u00a0Tertiary healthcare facility.\n\nMethods:\u00a0Case finding was by WHO Global AMR and Use Surveillance System (GLASS). Blood samples were processed between May 2017 and June 2018, using BACTEC blood culture system. Bacterial identification, antibiotic susceptibility testing and detection of AMR genes followed standard protocols.\n\nResults:\u00a0Aerobic blood cultures were conducted in a third of clinical sepsis cases (n\u00a0= 601\/1851), of which 114 (19.0%) were true positives, with a 2.2% contamination rate. Pathogens recovered included six priority blood pathogens reportable to WHO GLASS. Sixteen (30.2%) of 53 Gram-negative isolates were extended-spectrum beta-lactamase producers, predominantly harbouring\u00a0blaCTX-M,\u00a0three (5.7%) were AmpC beta-lactamase producers, and 20 (37.7%) were carbapenem-resistant, predominantly harbouring\u00a0blaKPC. Twenty-nine (50.9%) of 57\u00a0Staphylococcus aureus\u00a0isolates were methicillin-resistant; 17 (58.6%) of these harboured\u00a0mecA genes. Hospital-acquired infection (odds ratio [OR] = 0.3, 95% confidence interval [CI]=0.1\u20130.7,\u00a0p\u00a0= 0.004) was identified as a predisposing factor for the development of multidrug-resistant (MDR) bacteraemia. Bacteraemia with MDR organisms was significantly associated with mortality (OR = 3.8, 95% CI = 1.6\u20139.1,\u00a0p\u00a0= 0.001).\n\nConclusion:\u00a0A wide variety of bacteria are responsible for bacteraemia in our setting, with more than half being multidrug-resistant. Bacteraemia with multidrug-resistant organisms was significantly associated with mortality, hence, the need for this AMR surveillance initiative.\n\nContribution:\u00a0Implementing healthcare facility-based surveillance of AMR in LMICs is achievable despite limited microbiological laboratory capacity.<\/jats:p>","DOI":"10.4102\/jphia.v16i1.655","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:35:22Z","timestamp":1741851322000},"update-policy":"https:\/\/doi.org\/10.4102\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Bacteraemia in a Nigerian hospital: Implementing antimicrobial resistance surveillance"],"prefix":"10.4102","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-6732","authenticated-orcid":false,"given":"Adewale A.","family":"Amupitan","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bkbs460","id-type":"ROR","asserted-by":"publisher"}],"name":"Obafemi Awolowo University Teaching Hospitals Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-2530","authenticated-orcid":false,"given":"Adeyemi T.","family":"Adeyemo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bkbs460","id-type":"ROR","asserted-by":"publisher"}],"name":"Obafemi Awolowo University Teaching Hospitals Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7788-6328","authenticated-orcid":false,"given":"Adefunke O.","family":"Amupitan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05np2xn95","id-type":"ROR","asserted-by":"publisher"}],"name":"Kwara State University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4221-7158","authenticated-orcid":false,"given":"Temitope O.","family":"Obadare","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bkbs460","id-type":"ROR","asserted-by":"publisher"}],"name":"Obafemi Awolowo University Teaching Hospitals Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4280-2218","authenticated-orcid":false,"given":"Aaron O.","family":"Aboderin","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05bkbs460","id-type":"ROR","asserted-by":"publisher"}],"name":"Obafemi Awolowo University Teaching Hospitals Complex"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2580","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Lim C, Ashley EA, Hamers RL, et al. Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries. Clin Microbiol Infect. 2021;27(10):1391\u20131399. https:\/\/doi.org\/10.1016\/j.cmi.2021.05.037","DOI":"10.1016\/j.cmi.2021.05.037"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Okeke IN, Feasey N, Parkhill J, et al. Leapfrogging laboratories: The promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Glob Health. 2020;5(12):1\u20139. https:\/\/doi.org\/10.1136\/bmjgh-2020-003622","DOI":"10.1136\/bmjgh-2020-003622"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Musicha P, Cornick JE, Bar-Zeev N, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998\u20132016): A surveillance study. Lancet Infect Dis. 2017;17(10):1042\u20131052. https:\/\/doi.org\/10.1016\/S1473-3099(17)30394-8","DOI":"10.1016\/S1473-3099(17)30394-8"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"ref4","unstructured":"World Health Organization. Global antimicrobial resistance surveillance system: manual for early implementation. Geneva: WHO Press; 2015; 1\u201336."},{"key":"ref5","unstructured":"World Health Organization. Diagnostic stewardship. A guide to implementation in antimicrobial resistance surveillance sites. Geneva: WHO Press; 2016; 1\u201317."},{"key":"ref6","unstructured":"World Health Organization. Glass guidance for national reference laboratories. Geneva: WHO Press; 2020; 1\u201319."},{"key":"ref7","unstructured":"Abiodun Egwuenu. Guideline for antimicrobial resistance laboratory surveillance for laboratories in Nigeria. Abuja: Nigeria Centre for Disease Control; 2018; 168."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wasihun AG, Wlekidan LN, Gebremariam SA, et al. Bacteriological profile and antimicrobial susceptibility patterns of blood culture isolates among febrile patients in Mekelle Hospital, Northern Ethiopia. Springerplus. 2015;4(1):314. https:\/\/doi.org\/10.1186\/s40064-015-1056-x","DOI":"10.1186\/s40064-015-1056-x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care\u2013associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309\u2013332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002","DOI":"10.1016\/j.ajic.2008.03.002"},{"key":"ref10","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018."},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"O\u2019Brien T. WHONET: An information system for monitoring antimicrobial resistance. Emerg Infect Dis. 1995;1(2):66\u201366. https:\/\/doi.org\/10.3201\/eid0102.950209","DOI":"10.3201\/eid0102.950209"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sinha P, Sharma R, Rishi S, Sharma R, Sood S, Pathak D. Prevalence of extended spectrum beta lactamase and AmpC beta lactamase producers among Escherichia coli isolates in a tertiary care hospital in Jaipur. Indian J Pathol Microbiol. 2008;51(3):367\u2013369. https:\/\/doi.org\/10.4103\/0377-4929.42512","DOI":"10.4103\/0377-4929.42512"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Nahaei MR, Shahmohammadi MR, Ebrahimi S, Milani M. Detection of methicillin-resistant coagulase-negative staphylococci and surveillance of antibacterial resistance in a multi-center study from iran. Jundishapur J Microbiol. 2015;8(8):e19945. https:\/\/doi.org\/10.5812\/jjm.19945v2","DOI":"10.5812\/jjm.19945v2"},{"key":"ref14","unstructured":"Bali EB, Ac\u0131k L, Sultan N. Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum beta-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res [serial online]. 2010 [cited 2017 Apr 15];4(8):650\u2013654. Available from: http:\/\/www.academicjournals.org\/journal\/AJMR\/article-abstract\/1FC9DE412489"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Lowings M, Ehlers MM, Dreyer AW, Kock MM. High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa \u2013 An update. BMC Infect Dis. 2015;15:521. https:\/\/doi.org\/10.1186\/s12879-015-1246-8","DOI":"10.1186\/s12879-015-1246-8"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance. Infect Dis Clin Pract. 2001;10(5):294. https:\/\/doi.org\/10.1097\/00019048-200106000-00032","DOI":"10.1097\/00019048-200106000-00032"},{"key":"ref17","unstructured":"Mokuolu AO, Jiya N, Adesiyun OO. Neonatal septicaemia in Ilorin: Bacterial pathogens and antibiotic sensitivity pattern. Afr J Med Med Sci [serial online]. 2002 [cited 2017 May 25];31(2):127\u2013130. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12518907"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Moremi N, Claus H, Mshana SE. Antimicrobial resistance pattern: A report of microbiological cultures at a tertiary hospital in Tanzania. BMC Infect Dis. 2016;16(1):1\u20137. https:\/\/doi.org\/10.1186\/s12879-016-2082-1","DOI":"10.1186\/s12879-016-2082-1"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Bernab\u00e9 KJ, Langendorf C, Ford N, Ronat J, Murphy RA. Antimicrobial resistance in West Africa: A systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):629\u2013639. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.07.002","DOI":"10.1016\/j.ijantimicag.2017.07.002"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Ahmed D, Nahid MA, Sami AB, et al. Bacterial etiology of bloodstream infections and antimicrobial resistance in Dhaka, Bangladesh, 2005\u20132014. Antimicrob Resist Infect Control. 2017;6(1):1\u201311. https:\/\/doi.org\/10.1186\/s13756-016-0162-z","DOI":"10.1186\/s13756-016-0162-z"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Phe T, De Smet B, Veng HC, et al. Bloodstream infection among adults in Phnom Penh, Cambodia: Key pathogens and resistance patterns. PLoS One. 2013;8(3):1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0059775","DOI":"10.1371\/journal.pone.0059775"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Grewal US, Bakshi R, Walia GSP. Antibiotic susceptibility profiles of non-fermenting gram-negative Bacilli at a Tertiary Care Hospital in Patiala, India. Niger Postgr Med J. 2017;24(2):121\u2013125. https:\/\/doi.org\/10.4103\/npmj.npmj_76_17","DOI":"10.4103\/npmj.npmj_76_17"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Joo EJ. Microbiological and genotypic factors affecting mortality in methicillin-resistant Staphylococcus aureus bacteraemia. Korean J Intern Med. 2019;34(1):63\u201364.","DOI":"10.3904\/kjim.2018.435"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: A multicenter retrospective study. BMC Public Health. 2018;18(1):1\u20138. https:\/\/doi.org\/10.1186\/s12889-018-6013-5","DOI":"10.1186\/s12889-018-6013-5"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Day MJ, Rodr\u0131 I, Schink A, et al. Diversity of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in Germany, the Netherlands and the UK. J Antimicrob Chemother. 2016;2009(January):1178\u20131182. https:\/\/doi.org\/10.1093\/jac\/dkv485","DOI":"10.1093\/jac\/dkv485"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Xiao T, Wu Z, Shi Q, et al. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase ESBL-producing Escherichia coli bloodstream infections. J Glob Antimicrob Resist. 2019;17:147\u2013156. https:\/\/doi.org\/10.1016\/J.JGAR.2018.12.014","DOI":"10.1016\/j.jgar.2018.12.014"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Id MMCL, Bernards AT, Van Der Beek MT, et al. Epidemiological study of secondary bloodstream infections: The forgotten issue. BMC Infect Dis. 2018;11(1):1\u201311. https:\/\/doi.org\/10.4103\/1117-1936.190340","DOI":"10.4103\/1117-1936.190340"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Patolia S, Abate G, Patel N, Patolia S, Frey S. Risk factors and outcomes for multidrugresistant Gram-negative bacilli bacteremia. Ther Adv Infect Dis. 2018;5(1):11\u201318. https:\/\/doi.org\/10.1177\/2049936117727497","DOI":"10.1177\/2049936117727497"},{"key":"ref29","unstructured":"Fleming Fund-Nigeria. Nigeria: Country grant [homepage on the Internet]. Fleming Fund; 2019 [cited 2025 Jan]. Available from: https:\/\/www.flemingfund.org\/grants\/nigeria-country-grant\/"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Mo Y, Ding Y, Cao Y, et al. ACORN (A clinically-oriented antimicrobial resistance surveillance network) II: protocol for case-based antimicrobial resistance surveillance. Wellcome Open Res. 2023;8:179. https:\/\/doi.org\/10.12688\/wellcomeopenres.19210.2.","DOI":"10.12688\/wellcomeopenres.19210.1"}],"container-title":["Journal of Public Health in Africa"],"original-title":[],"link":[{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/655\/html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/655\/epub","content-type":"application\/epub+zip","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/655\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/viewFile\/655\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/view\/655\/1380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T11:37:04Z","timestamp":1773056224000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealthinafrica.org\/index.php\/jphia\/article\/view\/655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.4102\/jphia.v16i1.655","relation":{},"ISSN":["2038-9922","2038-9930"],"issn-type":[{"value":"2038-9922","type":"print"},{"value":"2038-9930","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"article-number":"a655"}}